89bio Inc (ETNB)
8.26
+0.01
(+0.12%)
USD |
NASDAQ |
Apr 26, 12:10
89bio Price: 8.26 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 8.44 | 8.46 | 8.04 | 8.25 | 1.008M |
Apr 24, 2024 | 8.92 | 9.105 | 8.54 | 8.58 | 871176.0 |
Apr 23, 2024 | 9.31 | 9.57 | 8.92 | 8.92 | 745431.0 |
Apr 22, 2024 | 9.43 | 9.78 | 9.12 | 9.31 | 580198.0 |
Apr 19, 2024 | 8.89 | 9.10 | 8.78 | 9.08 | 1.009M |
Apr 18, 2024 | 9.15 | 9.34 | 8.86 | 8.88 | 675448.0 |
Apr 17, 2024 | 9.44 | 9.57 | 9.115 | 9.16 | 686556.0 |
Apr 16, 2024 | 9.41 | 9.56 | 9.25 | 9.37 | 548713.0 |
Apr 15, 2024 | 10.03 | 10.03 | 9.41 | 9.49 | 670955.0 |
Apr 12, 2024 | 10.10 | 10.18 | 9.65 | 9.82 | 722277.0 |
Apr 11, 2024 | 10.59 | 10.64 | 10.06 | 10.14 | 1.347M |
Apr 10, 2024 | 10.53 | 10.60 | 10.34 | 10.54 | 1.027M |
Apr 09, 2024 | 10.78 | 10.97 | 10.61 | 10.90 | 614925.0 |
Apr 08, 2024 | 10.83 | 10.93 | 10.65 | 10.79 | 337381.0 |
Apr 05, 2024 | 10.54 | 10.84 | 10.25 | 10.76 | 408168.0 |
Apr 04, 2024 | 10.82 | 11.17 | 10.49 | 10.65 | 887158.0 |
Apr 03, 2024 | 10.55 | 10.90 | 10.34 | 10.87 | 936752.0 |
Apr 02, 2024 | 10.53 | 10.66 | 10.17 | 10.58 | 903255.0 |
Apr 01, 2024 | 11.51 | 11.58 | 10.64 | 10.73 | 948482.0 |
Mar 28, 2024 | 11.52 | 11.69 | 11.01 | 11.64 | 840223.0 |
Mar 27, 2024 | 11.25 | 11.62 | 11.00 | 11.31 | 1.297M |
Mar 26, 2024 | 11.53 | 11.62 | 11.18 | 11.20 | 568833.0 |
Mar 25, 2024 | 11.48 | 11.76 | 11.31 | 11.34 | 549165.0 |
Mar 22, 2024 | 11.44 | 11.89 | 11.37 | 11.50 | 760821.0 |
Mar 21, 2024 | 11.46 | 11.88 | 11.36 | 11.45 | 797147.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.09
Minimum
May 09 2022
41.77
Maximum
Mar 02 2020
16.77
Average
16.86
Median
Price Benchmarks
Madrigal Pharmaceuticals Inc | 192.58 |
Akero Therapeutics Inc | 19.23 |
Viking Therapeutics Inc | 68.67 |
Galectin Therapeutics Inc | 3.53 |
Terns Pharmaceuticals Inc | 4.77 |
Price Related Metrics
Price to Book Value | 1.467 |
Earnings Yield | -24.33% |
Market Cap | 786.56M |